HomeCompareABBV vs INTU

ABBV vs INTU: Dividend Comparison 2026

ABBV yields 3.12% · INTU yields 1.08%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 INTU wins by $4.21M in total portfolio value· pulled ahead in Year 6
10 years
ABBV
AbbVie Inc.
● Live price
3.12%
Share price
$213.22
Annual div
$6.65
5Y div CAGR
40.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$104.7K
Annual income
$25,725.73
Full ABBV calculator →
INTU
INTU
● Live price
1.08%
Share price
$429.03
Annual div
$4.64
5Y div CAGR
97.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.31M
Annual income
$3,591,875.66
Full INTU calculator →

Portfolio growth — ABBV vs INTU

📍 INTU pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodABBVINTU
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ABBV + INTU cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ABBV pays
INTU pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ABBV
Annual income on $10K today (after 15% tax)
$265.10/yr
After 10yr DRIP, annual income (after tax)
$21,866.87/yr
INTU
Annual income on $10K today (after 15% tax)
$91.93/yr
After 10yr DRIP, annual income (after tax)
$3,053,094.31/yr
At 15% tax rate, INTU beats the other by $3,031,227.44/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ABBV + INTU for your $10,000?

ABBV: 50%INTU: 50%
100% INTU50/50100% ABBV
Portfolio after 10yr
$2.21M
Annual income
$1,808,800.69/yr
Blended yield
81.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on INTU right now

ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+20.1% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
INTU
Analyst Ratings
32
Buy
8
Hold
3
Sell
Consensus: Buy
Price Target
$666.75
+55.4% upside vs current
Range: $540.00 — $875.00
Altman Z
6.8
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ABBV buys
7
INTU buys
9
PoliticianChamberTickerTypeAmountDate
Markwayne Mullin🏛 Senate$INTU▼ Sell$15,001 - $50,0002026-02-25
Josh Gottheimer🏢 House$INTU▼ Sell$1,001 - $15,0002026-02-20
Richard W. Allen🏢 House$INTU▼ Sell$1,001 - $15,0002026-02-19
Richard W. Allen🏢 House$INTU▼ Sell$15,001 - $50,0002026-02-18
Julia Letlow🏢 House$INTU▼ Sell$1,001 - $15,0002026-02-02
Michael McCaul🏢 House$INTU▲ Buy$1,001 - $15,0002026-01-30
Markwayne Mullin🏛 Senate$INTU▲ Buy$15,001 - $50,0002025-12-29
Markwayne Mullin🏛 Senate$INTU▲ Buy$15,001 - $50,0002025-12-29
Julie Johnson🏢 House$ABBV▼ Sell$1,001 - $15,0002025-12-18
Julia Letlow🏢 House$ABBV▼ Sell$1,001 - $15,0002025-12-08
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricABBVINTU
Forward yield3.12%1.08%
Annual dividend / share$6.65$4.64
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR40.6%97.6%
Portfolio after 10y$104.7K$4.31M
Annual income after 10y$25,725.73$3,591,875.66
Total dividends collected$63.0K$4.23M
Payment frequencyquarterlyquarterly
SectorHealthcareTechnology
Analyst consensusBuyBuy
Analyst price target$256.15$666.75

Year-by-year: ABBV vs INTU ($10,000, DRIP)

YearABBV PortfolioABBV Income/yrINTU PortfolioINTU Income/yrGap
1$11,559$438.51$10,914$213.71+$645.00ABBV
2$13,494$640.86$12,108$430.72+$1.4KABBV
3$15,951$945.97$13,838$882.49+$2.1KABBV
4$19,152$1,413.89$16,670$1,862.58+$2.5KABBV
5$23,443$2,146.38$21,980$4,143.42+$1.5KABBV
6← crossover$29,391$3,321.96$33,608$10,089.31$4.2KINTU
7$37,948$5,265.87$64,450$28,489.06$26.5KINTU
8$50,795$8,596.74$169,854$100,892.59$119.1KINTU
9$71,034$14,549.41$672,784$491,040.52$601.8KINTU
10$104,715$25,725.73$4,311,754$3,591,875.66$4.21MINTU

ABBV vs INTU: Complete Analysis 2026

ABBVHealthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Full ABBV Calculator →

INTUTechnology

Intuit Inc. provides financial management and compliance products and services for consumers, small businesses, self-employed, and accounting professionals in the United States, Canada, and internationally. The company operates in four segments: Small Business & Self-Employed, Consumer, Credit Karma, and ProConnect. The Small Business & Self-Employed segment provides QuickBooks online services and desktop software solutions comprising QuickBooks Online Advanced, a cloud-based solution; QuickBooks Enterprise, a hosted solution; QuickBooks Self-Employed solution; QuickBooks Commerce, a solution for product-based businesses; QuickBooks Online Accountant and QuickBooks Accountant Desktop Plus solutions; and payroll solutions, such as online payroll processing, direct deposit of employee paychecks, payroll reports, electronic payment of federal and state payroll taxes, and electronic filing of federal and state payroll tax forms. This segment also offers payment-processing solutions, including credit and debit cards, Apple Pay, and ACH payment services; QuickBooks Cash business bank account; and financial supplies and financing for small businesses. The Consumer segment provides TurboTax income tax preparation products and services; and personal finance. The Credit Karma segment offers consumers with a personal finance platform that provides personalized recommendations of home, auto, and personal loans, as well as credit cards and insurance products. The ProConnect segment provides Lacerte, ProSeries, and ProFile desktop tax-preparation software products; and ProConnect Tax Online tax products, electronic tax filing service, and bank products and related services. It sells products and services through various sales and distribution channels, including multi-channel shop-and-buy experiences, websites and call centers, mobile application stores, and retail and other channels. The company was founded in 1983 and is headquartered in Mountain View, California.

Full INTU Calculator →
📬

Get this ABBV vs INTU comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ABBV vs JNJABBV vs MRKABBV vs PFEABBV vs BMYABBV vs LLYABBV vs SCHDABBV vs JEPIABBV vs O

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.